Evidence map›Paper›PMID 35482251›Full record

ArticleAdvances in therapy2022

Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global Perspective.

Mohit Bhutani, David B Price, Tonya A Winders, Heinrich Worth, Kevin Gruffydd-Jones, Ruth Tal-Singer, Jaime Correia-de-Sousa, Mark T Dransfield, Rudi Peché, Daiana Stolz and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Advances in therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 8 countries.

Mohit BhutaniDivision of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
David B PriceCentre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
Tonya A WindersAllergy and Asthma Network, Global Allergy and Airways Patient Platform, Vienna, VA, USA.
Heinrich WorthFacharztforum Fürth, Fürth, Germany.
Kevin Gruffydd-JonesWarminster, Primary Health Care Centre, Wiltshire, UK.
Ruth Tal-SingerCOPD Foundation, Washington, DC, USA.
Jaime Correia-de-SousaLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga Portugal. ICVS/3B's, PT Government Associate Laboratory, Braga/Guimarães, Portugal.
Mark T DransfieldSchool of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Rudi PechéDepartment of Pneumology, ISPPC, CHU Charleroi, Charleroi, Belgium.
Daiana StolzClinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland.
John R HurstUCL Respiratory, University College London, Gower St, London, WC1E 6BT, UK. j.hurst@ucl.ac.uk.
COPD Foundation · USGrand Charleroi Hospital · BEKlinikum Fürth · DEUniversity College London · GBUniversity Medical Center Freiburg · DEUniversity of Aberdeen · GBUniversity of Alabama at Birmingham · USUniversity of Alberta · CAUniversity of Minho · PTWiltshire College · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDespite being a leading cause of death worldwide, chronic obstructive pulmonary disease (COPD) is underdiagnosed and underprioritized within healthcare systems. Existing healthcare policies should be revisited to include COPD prevention and management as a global priority. Here, we propose and describe health system quality standard position statements that should be implemented as a consistent standard of care for patients with COPD.

methodsA multidisciplinary group of clinicians with expertise in COPD management together with patient advocates from eight countries participated in a quality standards review meeting convened in April 2021. The principal objective was to achieve consensus on global health system priorities to ensure consistent standards of care for COPD. These quality standard position statements were either evidence-based or reflected the combined views of the panel.

resultsOn the basis of discussions, the experts adopted five quality standard position statements, including the rationale for their inclusion, supporting clinical evidence, and essential criteria for quality metrics. These quality standard position statements emphasize the core elements of COPD care, including (1) diagnosis, (2) adequate patient and caregiver education, (3) access to medical and nonmedical treatments aligned with the latest evidence-based recommendations and appropriate management by a respiratory specialist when required, (4) appropriate management of acute COPD exacerbations, and (5) regular patient and caregiver follow-up for care plan reviews.

conclusionsThese practical quality standards may be applicable to and implemented at both local and national levels. While universally applicable to the core elements of appropriate COPD care, they can be adapted to consider differences in healthcare resources and priorities, organizational structure, and care delivery capabilities of individual healthcare systems. We encourage the adoption of these global quality standards by policymakers and healthcare practitioners alike to inform national and regional health system policy revisions to improve the quality and consistency of COPD care worldwide.

Indexed as

Pulmonary Disease, Chronic ObstructiveGlobal HealthHealth PolicyHumansCOPDGlobal quality standard position statementsManagementPolicy

Identifiers

PMID35482251
PMCPMC9047462
OpenAlexW4224992031

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.